Fennec Pharmaceuticals (FENC) Shareholder's Equity Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 704.09% |
| Sep 30, 2025 | 13.13% |
| Jun 30, 2025 | -449.96% |
| Mar 31, 2025 | -295.09% |
| Dec 31, 2024 | 49.48% |
| Sep 30, 2024 | 50.90% |
| Jun 30, 2024 | 86.05% |
| Mar 31, 2024 | 141.07% |
| Dec 31, 2023 | -352.39% |
| Sep 30, 2023 | -475.84% |
| Jun 30, 2023 | -213.89% |
| Mar 31, 2023 | -158.60% |
| Dec 31, 2022 | -116.29% |
| Sep 30, 2022 | -85.26% |
| Jun 30, 2022 | -61.67% |
| Mar 31, 2022 | -49.77% |
| Dec 31, 2021 | -45.74% |
| Sep 30, 2021 | -39.03% |
| Jun 30, 2021 | -38.32% |
| Mar 31, 2021 | 194.68% |
| Dec 31, 2020 | 144.80% |
| Sep 30, 2020 | 107.87% |
| Jun 30, 2020 | 119.26% |
| Mar 31, 2020 | -55.95% |
| Dec 31, 2019 | -44.28% |
| Sep 30, 2019 | -34.37% |
| Jun 30, 2019 | -33.72% |
| Mar 31, 2019 | -25.16% |
| Dec 31, 2018 | -20.35% |
| Sep 30, 2018 | 158.06% |
| Jun 30, 2018 | 156.81% |
| Mar 31, 2018 | 796.99% |
| Dec 31, 2017 | 649.50% |
| Sep 30, 2017 | 109.91% |
| Jun 30, 2017 | 108.02% |
| Mar 31, 2017 | 1,077.37% |
| Dec 31, 2016 | 551.46% |
| Sep 30, 2016 | 314.13% |
| Jun 30, 2016 | 318.44% |
| Mar 31, 2016 | -70.58% |
| Dec 31, 2015 | -10.60% |
| Sep 30, 2015 | 131.57% |
| Jun 30, 2015 | 123.87% |
| Mar 31, 2015 | 119.06% |
| Dec 31, 2014 | 142.13% |
| Sep 30, 2014 | 21.78% |
| Jun 30, 2014 | -91.77% |
| Mar 31, 2014 | 52.19% |
| Dec 31, 2013 | 70.65% |
| Sep 30, 2013 | -421.42% |
| Jun 30, 2013 | -218.78% |
| Mar 31, 2013 | -449.33% |
| Dec 31, 2012 | -4,030.83% |
| Sep 30, 2012 | 134.99% |
| Jun 30, 2012 | 398.98% |
| Mar 31, 2012 | 1,016.96% |
| Dec 31, 2011 | 97.56% |